- Home
- BNZI vs ONCO Comparison
BNZI vs ONCO Comparison
Compare BNZI & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- ONCO
- Stock Information
- Founded
- BNZI 2016
- ONCO 2018
- Country
- BNZI United States
- ONCO United States
- Employees
- BNZI N/A
- ONCO N/A
- Industry
- BNZI
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- ONCO Health Care
- Exchange
- BNZI Nasdaq
- ONCO Nasdaq
- Market Cap
- BNZI 11.5M
- ONCO 1.8M
- IPO Year
- BNZI N/A
- ONCO 2022
- Fundamental
- Price
- BNZI $4.16
- ONCO $4.23
- Analyst Decision
- BNZI Strong Buy
- ONCO
- Analyst Count
- BNZI 1
- ONCO 0
- Target Price
- BNZI $24.00
- ONCO N/A
- AVG Volume (30 Days)
- BNZI 481.0K
- ONCO 229.9K
- Earning Date
- BNZI 08-13-2025
- ONCO 08-28-2025
- Dividend Yield
- BNZI N/A
- ONCO N/A
- EPS Growth
- BNZI N/A
- ONCO N/A
- EPS
- BNZI N/A
- ONCO N/A
- Revenue
- BNZI $6,827,490.00
- ONCO $1,925,313.00
- Revenue This Year
- BNZI $337.60
- ONCO N/A
- Revenue Next Year
- BNZI $91.81
- ONCO N/A
- P/E Ratio
- BNZI N/A
- ONCO N/A
- Revenue Growth
- BNZI 52.95
- ONCO 153.70
- 52 Week Low
- BNZI $3.93
- ONCO $3.82
- 52 Week High
- BNZI $112.00
- ONCO $1,190.00
- Technical
- Relative Strength Index (RSI)
- BNZI 24.16
- ONCO 40.01
- Support Level
- BNZI $4.11
- ONCO $4.19
- Resistance Level
- BNZI $6.90
- ONCO $5.17
- Average True Range (ATR)
- BNZI 0.69
- ONCO 0.45
- MACD
- BNZI -0.10
- ONCO 0.07
- Stochastic Oscillator
- BNZI 4.03
- ONCO 21.76
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.